Plasma gelsolin as a potential biomarker for Henoch– Schoenlein purpura

Scandinavian Journal of Rheumatology

Volumn 46, Issue 2, 2017, Pages 166-168

  Kandur, Y ^a   Celik A ^b   Gozubenli F ^a   Cetinkaya A ^b   Olgar, S ^b  

^a Necip Fazil City Hospital   (Turkey)

^b KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; GELSOLIN; HEMOGLOBIN; SERUM ALBUMIN; BIOLOGICAL MARKER;

ABDOMINAL PAIN; ALBUMIN BLOOD LEVEL; ANAPHYLACTOID PURPURA; ANTHROPOMETRIC PARAMETERS; ARTHRALGIA; ARTHRITIS; BLOOD SAMPLING; BODY HEIGHT; BODY WEIGHT; CHILD; CHILDHOOD DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATURIA; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; LETTER; LEUKOCYTE COUNT; MALE; MICROSCOPY; MULTICENTER STUDY (TOPIC); OCCULT BLOOD; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SEX DIFFERENCE; TIME TO TREATMENT; URINALYSIS; VENOUS BLOOD; BLOOD; COMPLICATION; DISEASE COURSE; JOINT DISEASES; KIDNEY DISEASES; PATHOPHYSIOLOGY; PATIENT ACUITY; PROTECTION; PURPURA, SCHOENLEIN-HENOCH; TURKEY;

ABDOMINAL PAIN; BIOMARKERS; CHILD; DISEASE PROGRESSION; FEMALE; GELSOLIN; HUMANS; JOINT DISEASES; KIDNEY DISEASES; MALE; PATIENT ACUITY; PROSPECTIVE STUDIES; PROTECTIVE FACTORS; PURPURA, SCHOENLEIN-HENOCH; TURKEY;

EID: 84984682146     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009742.2016.1209552     Document Type: Letter

References (11)

1. Bagga A, Dillon MJ., Leukocytoclastic vasculitis. In:Cassidy JT, Petty RE, editors. Textbook of Pediatric Rheumatology, 4th edn. London:Elsevier Health Sciences, 2001:569–74.
2. Teng X, Wang Y, Lin N, Sun M, Wu J. Evaluation of serum procalcitonin and C-reactive protein levels as biomarkers of Henoch-Schönlein purpura in pediatric patients. Clin Rheumatol 2016;35:667–71.
3. Ha TS. The role of tumor necrosis factor-alpha in Henoch-Schonlein purpura. Pediatr Nephrol 2005;20:149–53.
4. Suhler E, Lin W, Yin HL, Lee WM. Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis. Crit Care Med 1997;25:594–8.
5. Osborn TM, Verdrengh M, Stossel TP, Tarkowski A, Bokarewa M. Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis. Arthritis Res Ther 2008;10:117.
6. Argun M, Baykan A, Narin F, Özyurt A, Pamukçu Ö, Elmalı F, et al. Plasma gelsolin as a biomarker of acute rheumatic carditis. Cardiol Young 2015;25:1276–80.
7. Davin JC, Ten Berge IJ, Weening JJ. What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? Kidney Int 2001;59:823–34.
8. Osborn TM, Dahlgren C, Hartwig JH, Stossel TP. Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin. Am J Physiol Cell Physiol 2007;292:C1323–30.
9. Calvino MC, Llorca J, Garcin-Porrua C, Fernandez-Iglesias JL, Rodriguez-Ledo P, Gonzalez-Gay MA. Henoch-Schonlein purpura in children from northwestern Spain. A 20–year epidemiologic and clinical study. Medicine (Baltimore) 2001;80:279–90.
10. Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, et al. Henoch Schonlein purpura in childhood:epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 2005;35:143–53.
11. Goldstein AR, White RH, Akuse R, Chantler C. Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet 1992;339:280–2.